PHARMACOKINETICS OF ATENOLOL IN RELATION TO RENAL-FUNCTION

被引：48

作者：

KIRCH, W ^{[1
]}

KOHLER, H ^{[1
]}

MUTSCHLER, E ^{[1
]}

SCHAFER, M ^{[1
]}

机构：

[1] UNIV FRANKFURT,PHARMAKOL INST NAT WISSENSCH,D-6000 FRANKFURT 70,FED REP GER

来源：

关键词：

D O I：

10.1007/BF00558387

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：65 / 71

页数：7

共 20 条

[1] ABENDROTH RR, 1977, Z KARDIOL, V66, P341
[2] BARRETT AM, 1973, BRIT J PHARMACOL, V48, pP340
[3] BROWN HC, 1976, CLIN PHARMACOL THER, V20, P524
[4] CLINICAL PHARMACOLOGY OF BETA-ADRENOCEPTOR-BLOCKING DRUGS
CONOLLY, ME
KERSTING, F
DOLLERY, CT
[J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1976, 19 (03) : 203 - 234
[5] HUMAN PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES ON ATENOLOL (ICI 66,082), A NEW CARDIOSELECTIVE BETA-ADRENOCEPTOR BLOCKING DRUG
CONWAY, FJ
FITZ GERALD, JD
MCAINSH, J
ROWLANDS, DJ
SIMPSON, WT
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (02) : 267 - 272
[6] DECALMER PBS, 1978, BRIT HEART J, V40, P184
[7] DETTLI L, 1977, PROG PHARMACOL, V1
[8] ERIKSSEN J, 1977, ACTA MED SCAND, V201, P579
[9] KODA RT, 1977, CLIN PHARMACOL THER, V21, P108
[10] MASON WD, 1979, CLIN PHARMACOL THER, V25, P408